ABC | Volume 114, Nº4, April 2020

Original Article Fernandes et al. Galectin-3 in pericardial constriction Arq Bras Cardiol. 2020; 114(4):683-689 1. Adler Y , Charron P , Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015; 36(42):2921–64. 2. Zurick AO, Bolen MA, Kwon DH, Tan CD, Popovic ZB, Rajeswaran J, et al. Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. JACC Cardiovasc Imaging. 2011; 4(11):1180–91. 3. Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP , Schroen B, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004; 110(19):3121–38. 4. FilipeMD, MeijersWC, Rogier van der Velde A, de Boer RA. Galectin-3 and heart failure: prognosis, prediction & clinical utility. Clin Chim Acta. 2015 Mar 30; 443:48-56. 5. Ntsekhe M, Matthews K, Wolske J, Badri M, Wilkinson KA, Wilkinson RJ, et al. Scientific letter: Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and Galectin-3 levels in tuberculous pericardial effusion: implications for pathogenesis and prevention of pericardial constriction. Heart. 2012; 98(17):1326–8. 6. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF , et al. American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Interdisciplinary Council on Quality of Care and Outcomes Research. Clinician’s Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010; 122(2):191–225. 7. Klein AL, Abbara S, Agler DA, Appleton CP , Asher CR, Hoit B, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013; 26(9):965–1012. 8. López B, González A, Querejeta R, Zubillaga E, LarmanM, Díez J. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin. Eur J Heart Fail. 2015; 17(4):385–92. 9. Imazio M, Brucato A, Maestroni S, Cumetti D, Belli R, Trinchero R, et al. Risk of constrictive pericarditis after cute pericarditis. Circulation. 2011; 124(11):1270–5. 10. Feng D, Glockner J, Kim K, Martinez M, Syed IS, Araoz P, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditisafter antiinflammatorymedicaltherapy: apilotstudy. Circulation. 2011;124(17):1830–7. 11. Bertog SC, Thambidorai SK, Parakh K, Schoenhagen P , Ozduran V, Houghtaling PL, et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol. 2004; 43(8):1445–52. 12. Ling LH, Oh JK, Schaff HV, Danielson GK, Mahoney DW , Seward JB, et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impactonoutcomeafterpericardiectomy.Circulation.1999;100(13):1380–6. 13. Piña IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, et al. American Heart Association Committee on exercise, rehabilitation, and prevention Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation. 2003; 107(8):1210-25. 14. Salemi VM, Leite JJ, Picard MH, Oliveira LM, Reis SF, Pena JL, et al. Echocardiographic predictors of functional capacity in endomyocardial fibrosis patients. Eur J Echocardiogr. 2009; 10(3):400-5. 15. Piña IL, Bittner V , Clare RM, Swank A, Kao A, Safford R, et al. HF-ACTION Investigators. Effects of exercise training on outcomes in women with heart failure: analysis of HF-ACTION (Heart Failure-AControlled Trial Investigating Outcomes of Exercise TraiNing) by sex. JACC Heart Fail. 2014; 2(2):180-6. References This is an open-access article distributed under the terms of the Creative Commons Attribution License 689